Literature DB >> 24839087

Stage-based approach to the management of fetal growth restriction.

Francesc Figueras1, Eduard Gratacos.   

Abstract

Fetal growth restriction (FGR) is among the obstetrical entities with the greatest variation in clinical practice. The first clinically relevant step in the management of FGR is the distinction of 'true' FGR, associated with signs of abnormal feto-placental function and poorer perinatal outcome, from small for gestational age fetuses, which do not present abnormal Doppler and have near normal perinatal outcome. Such distinction should not be only relied on umbilical artery Doppler, as this parameter identifies only severe, early-onset, forms of placental insufficiency. Instead, FGR should be diagnosed in the presence of any of the factors associated with a poorer perinatal outcome, including Doppler cerebroplacental ratio and uterine artery Doppler, a growth centile below the third centile. Upon diagnosis, differentiating into early-onset and late-onset FGR is useful to distinguish two clear phenotypes, with differences in severity, association with preeclampsia, and sequence of fetal deterioration. Finally, management of FGR aims at an optimal balance between minimizing fetal injury or death versus the risks of iatrogenic preterm delivery. We propose a protocol that integrates current evidence to classify stages of fetal deterioration, and establishes follow-up intervals and optimal delivery timings, which may facilitate decision-making and minimize variability in the clinical management.
© 2014 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24839087     DOI: 10.1002/pd.4412

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  24 in total

1.  Placental Complications and Bronchopulmonary Dysplasia: EPIPAGE-2 Cohort Study.

Authors:  Héloïse Torchin; Pierre-Yves Ancel; François Goffinet; Jean-Michel Hascoët; Patrick Truffert; Diep Tran; Cécile Lebeaux; Pierre-Henri Jarreau
Journal:  Pediatrics       Date:  2016-02-18       Impact factor: 7.124

2.  Predictive accuracy of the first trimester Doppler scan: a meta-study.

Authors:  Naira Roland Matevosyan
Journal:  Wien Med Wochenschr       Date:  2015-06-16

3.  Elemental Metabolomics for Prediction of Term Gestational Outcomes Utilising 18-Week Maternal Plasma and Urine Samples.

Authors:  Daniel R McKeating; Vicki L Clifton; Cameron P Hurst; Joshua J Fisher; William W Bennett; Anthony V Perkins
Journal:  Biol Trace Elem Res       Date:  2020-04-01       Impact factor: 3.738

4.  Hypoxia downregulates the angiogenesis in human placenta via Notch1 signaling pathway.

Authors:  Yu-Qi Li; Hai-Yi Liu; Lan-Lan Cao; Yuan-Yuan Wu; Xin-Wei Shi; Fu-Yuan Qiao; Ling Feng; Dong-Rui Deng; Xun Gong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

5.  A Low Cerebroplacental Ratio at 20-24 Weeks of Gestation Can Predict Reduced Fetal Size Later in Pregnancy or at Birth.

Authors:  Edgar Hernandez-Andrade; Eli Maymon; Offer Erez; Homam Saker; Suchaya Luewan; Maynor Garcia; Hyunyoung Ahn; Adi L Tarca; Bogdan Done; Steven J Korzeniewski; Sonia S Hassan; Roberto Romero
Journal:  Fetal Diagn Ther       Date:  2017-09-20       Impact factor: 2.587

6.  Perinatal outcomes of two consecutive strategies for the management of fetal growth restriction: a before-after study.

Authors:  Sabrina Paola Demirdjian; Cesar Hernan Meller; Maria Celeste Berruet; Gonzalo Dosdoglirian; Adolfo Etchegaray
Journal:  Arch Gynecol Obstet       Date:  2022-06-10       Impact factor: 2.344

7.  Efficacy of Pulsatility Index of Fetal Vessels in Predicting Adverse Perinatal Outcomes in Fetuses with Growth Restriction - Differences in Early- and Late-Onset Fetal Growth Restriction.

Authors:  Annapurna Srirambhatla; Saurabh Mittal; Haripriya Vedantham
Journal:  Maedica (Bucur)       Date:  2022-03

8.  Gestational nanomaterial exposures: microvascular implications during pregnancy, fetal development and adulthood.

Authors:  P A Stapleton
Journal:  J Physiol       Date:  2015-10-28       Impact factor: 5.182

9.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy E Whitten; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2016

Review 10.  Intrauterine Growth Restriction: Antenatal and Postnatal Aspects.

Authors:  Deepak Sharma; Sweta Shastri; Pradeep Sharma
Journal:  Clin Med Insights Pediatr       Date:  2016-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.